Professor Kausik Ray
Professor Ray is the President of the European Atherosclerosis Society, Professor of Public Health and Honorary Consultant Cardiologist at Imperial College London. Director of the Imperial Centre for Cardiovascular Disease Prevention and Deputy Director of the Imperial Clinical Trials Unit and Head of Commercial Trials, Chief Clinical Officer and Trials Lead DISCOVER NOW, HDR UK Innovation Hub NW London, and NIHR Academic Research Collaboration National Lead for CVD. A Clarivate top 1% Highly Cited Researcher in global medicine since 2018, his H index is 87, i10 is 221 and he has >94 000 citations. His key contributions have influenced European/US guidelines and led to FDA/EMEA label changes approvals for several novel therapies. He is the global PI for ORION 1,3,8,11 and BETonMACE, leads the EAS FHSC (a global FH registry of 68 countries and 64000 cases), Senior PI for TOGETHER studying cardiometabolic risk in 250000 people in London, PI for the Da Vinci, SANTORI and Heymans Pan-European Registries.